Zafgen Secures $21 Million in Series D Financing Read more about Zafgen Secures $21 Million in Series D Financing Zafgen Inc. Appoints Industry Veteran and Recognized Metabolic Disorders Expert Thomas Hughes, Ph.D., as Company’s First Chief Executive Officer Read more about Zafgen Inc. Appoints Industry Veteran and Recognized Metabolic Disorders Expert Thomas Hughes, Ph.D., as Company’s First Chief Executive Officer Zafgen Inc. to Present at First Annual Boston Biotech R&D Conference Read more about Zafgen Inc. to Present at First Annual Boston Biotech R&D Conference Argenta Discovery and Zafgen Announce Contract Drug Discovery Collaboration in Obesity Read more about Argenta Discovery and Zafgen Announce Contract Drug Discovery Collaboration in Obesity Zafgen, Inc. to Present at Upcoming Conferences Read more about Zafgen, Inc. to Present at Upcoming Conferences Zafgen, Inc. to Present at Xconomy Forum Read more about Zafgen, Inc. to Present at Xconomy Forum Zafgen, Inc. Appoints Matthias Jaffe to Chief Financial Officer and Vice President of Business Development Read more about Zafgen, Inc. Appoints Matthias Jaffe to Chief Financial Officer and Vice President of Business Development Zafgen, Inc. Announces Participation at BIO 2009 International Convention Read more about Zafgen, Inc. Announces Participation at BIO 2009 International Convention Groundbreaking Approach to Treating Obesity Highlighted by Keynote Lecture at American Diabetes Association Annual Scientific Sessions Read more about Groundbreaking Approach to Treating Obesity Highlighted by Keynote Lecture at American Diabetes Association Annual Scientific Sessions American Diabetes Association Awards Leaders in the Field Read more about American Diabetes Association Awards Leaders in the Field Pagination First page « First Previous page ‹ Previous … Page 17 Page 18 Page 19 Page 20 Page 21 Current page 22 Page 23 Page 24 Page 25 Next page Next › Last page Last » Subscribe to
Zafgen Secures $21 Million in Series D Financing Read more about Zafgen Secures $21 Million in Series D Financing
Zafgen Inc. Appoints Industry Veteran and Recognized Metabolic Disorders Expert Thomas Hughes, Ph.D., as Company’s First Chief Executive Officer Read more about Zafgen Inc. Appoints Industry Veteran and Recognized Metabolic Disorders Expert Thomas Hughes, Ph.D., as Company’s First Chief Executive Officer
Zafgen Inc. to Present at First Annual Boston Biotech R&D Conference Read more about Zafgen Inc. to Present at First Annual Boston Biotech R&D Conference
Argenta Discovery and Zafgen Announce Contract Drug Discovery Collaboration in Obesity Read more about Argenta Discovery and Zafgen Announce Contract Drug Discovery Collaboration in Obesity
Zafgen, Inc. to Present at Upcoming Conferences Read more about Zafgen, Inc. to Present at Upcoming Conferences
Zafgen, Inc. Appoints Matthias Jaffe to Chief Financial Officer and Vice President of Business Development Read more about Zafgen, Inc. Appoints Matthias Jaffe to Chief Financial Officer and Vice President of Business Development
Zafgen, Inc. Announces Participation at BIO 2009 International Convention Read more about Zafgen, Inc. Announces Participation at BIO 2009 International Convention
Groundbreaking Approach to Treating Obesity Highlighted by Keynote Lecture at American Diabetes Association Annual Scientific Sessions Read more about Groundbreaking Approach to Treating Obesity Highlighted by Keynote Lecture at American Diabetes Association Annual Scientific Sessions
American Diabetes Association Awards Leaders in the Field Read more about American Diabetes Association Awards Leaders in the Field